TriVascular Technologies (TRIV) Tops Q3 EPS by 5c

TriVascular Technologies (NASDAQ: TRIV) reported Q3 EPS of ($0.66), $0.05 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $9.28 million.

Adjusted EBITDA, a non-GAAP measure, was a loss of $10.1 million for the third quarter of 2015 compared to $11.4 million in the third quarter of 2014.

For earnings history and earnings-related data on TriVascular Technologies (TRIV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c